INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
45 hedge funds and large institutions have $32.2M invested in Infinity Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
45
Holding in Top 10
–
Calls
$81K
Puts
$3K
Top Buyers
| 1 | +$183K | |
| 2 | +$137K | |
| 3 | +$112K | |
| 4 |
Goldman Sachs
New York
|
+$64K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$60.3K |
Top Sellers
| 1 | -$699K | |
| 2 | -$141K | |
| 3 | -$18K | |
| 4 |
CB
Community Bank
Dewitt,
New York
|
-$14K |
| 5 |
Two Sigma Investments
New York
|
-$12K |